Target intelligence / Profile preview

Hyaluronan-binding protein (HABP)

Target
HABP
Molecular classification
Extracellular matrix protein, Cell surface receptor (e.g., CD44, LYVE-1, RHAMM, HARE), Structural protein (e.g., versican, aggrecan), Other (diverse superfamilies including Link module proteins and non-Link proteins)
01

Overview

Hyaluronan-binding proteins, or hyaladherins, are a class of molecules that bind selectively to hyaluronic acid, a major glycosaminoglycan of the extracellular matrix. They perform key structural and signaling functions, mediating cell adhesion, migration, and communication. Prominent examples include CD44, RHAMM, LYVE-1, Stabilin-2 (HARE), versican, and aggrecan. These proteins regulate diverse biological processes, including tissue hydration, inflammation, tumor metastasis, and tissue repair. Aberrant HA binding and turnover are implicated in diseases such as cancer, fibrosis, arthritis, and neurodegenerative disorders.

Other names
HyaladherinHyaluronan-binding proteinHA-binding proteinHABPLink module proteins (includes CD44, RHAMM, LYVE-1, HARE/Stabilin-2, versican, aggrecan, TSG-6, etc.)
02

Mechanism of action

Mechanisms include enzymatic degradation of hyaluronic acid (e.g., hyaluronidase), blocking HA-receptor interactions (e.g., anti-CD44 antibodies), modulation of ECM structure via inhibition or enhancement of HA-protein binding, and disrupting HA accumulation to enhance drug penetration in tumors.

03

Biological functions

Cell adhesionStructural support of the extracellular matrixCell signalingRegulation of cell migrationMaintenance of tissue hydration and homeostasisModulation of inflammationRegulation of tissue remodeling and repair
04

Disease associations

Cancer (tumor progression, metastasis)Inflammation (e.g., arthritis, tissue injury)FibrosisNeurodegenerative disease (e.g., brain ECM changes)Cardiovascular diseaseInfection
05

Safety considerations

Disruption of normal tissue homeostasis and hydrationPotential for promoting tissue injury or inflammation if HA metabolism or clearance is excessively alteredEffects on wound healing and immune regulation
06

Interacting drugs

Hyaluronidase (enzyme drugs degrading HA; used to modulate ECM)

2 more in the full profile.

07

Biomarkers

HA concentration in tissues or serum (used in liver disease, cancer)Expression levels of CD44 or other HA-receptors on cells

Beyond the preview

Go deeper on Hyaluronan-binding protein (HABP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hyaluronan-binding protein (HABP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call